SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-073237
Filing Date
2011-08-05
Accepted
2011-08-05 06:34:05
Documents
15
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b83415e10vq.htm 10-Q 372866
2 EX-10.1 b83415exv10w1.htm EX-10.1 8769
3 EX-10.2 b83415exv10w2.htm EX-10.2 8764
4 EX-10.5 b83415exv10w5.htm EX-10.5 33174
5 EX-31.1 b83415exv31w1.htm EX-31.1 5886
6 EX-31.2 b83415exv31w2.htm EX-31.2 6173
7 EX-32.1 b83415exv32w1.htm EX-32.1 3060
8 EX-32.2 b83415exv32w2.htm EX-32.2 3123
15 GRAPHIC b83415b8341500.gif GRAPHIC 6140
  Complete submission text file 0000950123-11-073237.txt   1593012

Data Files

Seq Description Document Type Size
9 EX-101 INSTANCE DOCUMENT idra-20110630.xml EX-101.INS 147778
10 EX-101 SCHEMA DOCUMENT idra-20110630.xsd EX-101.SCH 10704
11 EX-101 CALCULATION LINKBASE DOCUMENT idra-20110630_cal.xml EX-101.CAL 26536
12 EX-101 LABELS LINKBASE DOCUMENT idra-20110630_lab.xml EX-101.LAB 100829
13 EX-101 PRESENTATION LINKBASE DOCUMENT idra-20110630_pre.xml EX-101.PRE 65813
14 EX-101 DEFINITION LINKBASE DOCUMENT idra-20110630_def.xml EX-101.DEF 10240
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 111012111
SIC: 2836 Biological Products, (No Diagnostic Substances)